Sarepta Therapeutics, Inc. SRPT Business Segments — D&A

Similar metrics at other companies

NKTRAll Other Segments — D&A

$121K-69.3%

BANFAll Other Segments — D&A

$150K+4.9%

CAKEAll Other Segments — D&A

$4.26M+5.8%

RUSHBAll Other Segments — D&A

$148K+5.7%

UNFAll Other Segments — D&A

$818K+6.9%

CCAll Segments — D&A

$74M-9.8%

Questions, answered.

What is Sarepta Therapeutics, Inc.'s business segments — D&A?

Sarepta Therapeutics, Inc. (SRPT) reported business segments — D&A of $10.59M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s business segments — D&A changed year-over-year?

Sarepta Therapeutics, Inc.'s business segments — D&A increased by 6.2% year-over-year, from $9.98M to $10.59M.

What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — D&A?

Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — D&A has grown at a 2.1% compound annual growth rate (CAGR), from $41.86M to $44.52M.

What does business segments — D&A mean?

The non-cash expense allocated to the segment representing the systematic allocation of the cost of tangible and intangible assets over their useful lives. It reflects the consumption of capital assets required to maintain segment operations. Monitoring this helps assess the segment's capital intensity and asset replacement needs.